Brewster L, van Montfrans G, Oehlers G, Seedat Y
Intern Emerg Med. 2016; 11(3):355-74.
PMID: 27026378
PMC: 4820501.
DOI: 10.1007/s11739-016-1422-x.
Seedat Y
Br Med J. 1980; 281(6250):1241-3.
PMID: 7000296
PMC: 1714681.
DOI: 10.1136/bmj.281.6250.1241.
Grell G
Postgrad Med J. 1983; 59(696):616-21.
PMID: 6647170
PMC: 2417644.
DOI: 10.1136/pgmj.59.696.616.
Juma F
Eur J Clin Pharmacol. 1983; 25(3):425-6.
PMID: 6628532
DOI: 10.1007/BF01037959.
Williams E, Hassan M, Floras J, Sleight P, Jones J
Br Heart J. 1980; 44(5):473-87.
PMID: 6108122
PMC: 482432.
DOI: 10.1136/hrt.44.5.473.
Treatment of hypertension with propranolol.
Prichard B, GILLAM P
Br Med J. 1969; 1(5635):7-16.
PMID: 5761914
PMC: 1981816.
DOI: 10.1136/bmj.1.5635.7.
Controlled trial of oxprenolol and practolol in hypertension.
LEISHMAN A, THIRKETTLE J, Allen B, Dixon R
Br Med J. 1970; 4(5731):342-4.
PMID: 4394369
PMC: 1819715.
DOI: 10.1136/bmj.4.5731.342.
[Modification of sympathetic hyperactivity by drugs. Short-term pharmacologic experiments using parasympathomimetics and beta-receptor blockaders in humans].
von Eiff A, Czernik A, Zanders K
Klin Wochenschr. 1969; 47(13):701-8.
PMID: 4392685
DOI: 10.1007/BF01881620.
Beta-adrenergic receptor blocking drugs in hypertension.
Simpson F
Drugs. 1974; 7(1):85-105.
PMID: 4152167
DOI: 10.2165/00003495-197407010-00006.
Diabetes mellitus and hypertension in an African population.
Oli J, Ikeh V
J R Coll Physicians Lond. 1986; 20(1):32-5.
PMID: 3944773
PMC: 5371134.
Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.
Singh B, Thoden W, Ward A
Drugs. 1985; 29(6):531-69.
PMID: 3891306
DOI: 10.2165/00003495-198529060-00003.
Propranolol versus labetalol: interesting differences in efficacy.
Flamenbaum W
J Natl Med Assoc. 1985; 77 Suppl:14-23.
PMID: 3889356
PMC: 2561791.
Slow release nifedipine and atenolol as initial treatment in blacks with malignant hypertension.
Isles C, Johnson A, Milne F
Br J Clin Pharmacol. 1986; 21(4):377-83.
PMID: 3518771
PMC: 1400940.
DOI: 10.1111/j.1365-2125.1986.tb05210.x.
Cost effectiveness of labetalol and propranolol in the treatment of hypertension among blacks.
Oster G, Huse D, Delea T, Savage D, Colditz G
J Natl Med Assoc. 1987; 79(10):1049-55.
PMID: 3119865
PMC: 2625509.
Racial differences in drug responses--a comparative study of trimazosin and alpha 1-adrenoceptor responses in normotensive Caucasians and West Africans.
Vincent J, Elliott H, MEREDITH P, Reid J
Br J Clin Pharmacol. 1986; 21(4):401-8.
PMID: 3011048
PMC: 1400935.
DOI: 10.1111/j.1365-2125.1986.tb05214.x.
Ethnic differences in response to beta-blockade: fact or artefact? A study with bisoprolol and propranolol.
Joubert P, Venter C, Wellstein A
Eur J Clin Pharmacol. 1988; 34(4):363-8.
PMID: 2900144
DOI: 10.1007/BF00542437.
Beta blockers, hypertension, and blacks--is the answer really in?.
Veiga R, Taylor R
J Natl Med Assoc. 1986; 78(9):851-6.
PMID: 2878086
PMC: 2571367.
Relative potency of a beta-blocking and a calcium entry blocking agent as antihypertensive drugs in black patients.
MBuyamba-Kabangu J, Lepira B, Fagard R, Lijnen P, Ditu M, Tshiani K
Eur J Clin Pharmacol. 1986; 29(5):523-7.
PMID: 2869952
DOI: 10.1007/BF00635887.
The effects of propranolol or atenolol on the cardiovascular responses to central hypovolaemia in Europeans and Bengalees.
Rahman M, Bennett T
Br J Clin Pharmacol. 1990; 29(1):69-77.
PMID: 2297462
PMC: 1380063.
DOI: 10.1111/j.1365-2125.1990.tb03604.x.
Apparent racial difference in response to angiotensin I infusion.
Joubert P, Brandt H
Eur J Clin Pharmacol. 1990; 39(2):183-5.
PMID: 2253671
DOI: 10.1007/BF00280056.
